BioDiamond

Literature

1. Anderson HV, Roubin GS, Leimgruber PP, Douglas JS JR, King SB III, Grüntzinger AR. Primary angiographic success rates of percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 1985; 56: 712-717

2. Myler RK, Topol EJ, Shaw RE, Stertzer SH, Clark DA, Fishman J, et al.. Multiple vessel coronary angioplasty: classification, results and patterns of restenosis in 494 consecutive patients. Cath. Cardiovasc. Diag. 1987; 13: 1-15

3. Bredlau CE, Roubin GS, Leimgruber PP, Douglas JS JR, King SB III, Grüntzig AR.

4. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 1985; 72: 1044-1052

4. Simpfendorfer C, Belardi J, Bellamy G, Galain K, Franco I, Hollman J. Frequencies, management and follow-up of patients with acute coronary occulasion after percutaneous transluminal angioplasty. 1987; 59: 267-269

5. De Freyter PJ, van den Brand M, Laarman GJ, van Domburg RT, Serruys PW, Suryapranata H. Acute coronary artery occulation during and after percutaneous transluminal coronary angioplasty: frequency, prediction, clinical course, managment and follow-up. Circulation 1991; 83: 927-936

6. Serruys PW, Luijten HE, Beatt KJ, Feyer PJ DE, Brand M van den, Reiber JHC Incidence of restenose after successful coronary angioplasty: a time-related phenomenon. Circulation 1988; 77: 361-371

7. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Uendo K, Yokoi H, et. al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 299 patients. J. Am. Coll. Cardiol. 1988; 12: 616-623

8. Detre K, Holubokov R, Kelsey S, Coweley M, Kent K, Williams D, et. al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. N. Engl. J. Med. 1988; 318: 265-270

9. Blackshear JL, O'Callagham WG, Califf RM. Medical approaches to prevention of restenosis after coronary angioplasty. J. Am. Coll. Cardiol. 1987; 9: 834-848

10. Pompa JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991; 84: 1426-1436

11. Hermans WRM, Rensing BJ, Strauss BH, Serruys PW. Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a Ĉmagic bullet". 1991; 122: 171-187

12. Carrel A. Results of the permanent intubation of the thoracic aorta. Surg. Gynecol. Obstet 1912; 15: 245-248

13. Dotter CT. Transluminally-placed coilspring endarterial tube grafts: long-term patency in the canine popliteal artery. Invest. Radiol. 1969; 4: 329-332

14. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stent to prevent occulation and restenosis after transluminal angioplasty. N. Engl. J. Med. 1987; 316: 701-706

15. Serruyes PW, de Jaegere P, Kiemeneij F, et. al. on behalf of the Benestent Study Group: A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495

16. Fischman DL, Leon MB, Baim DS, et al.. A randomised comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501

17. Serruys PW, Strauss BH, Beatt KJ, Bertrand ME, Peul J, Rickards AF, et. al. Angiographic follow-up after placement of a selfe-expanding coronary-artery stent. N. Engl. J. Med. 1991; 324: 13-17

18. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JD, et. al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multi-center study. Circulation 1991; 83: 148-161

19. De Feyter PJ, De Scheerder I, Van Den Brand M, Laarman G, Suryapranata H, Serruys PW. Emergency stenting for refractory acute coronary artery occulation during coronary angioplasty. Am. J. Cardiol. 1990; 66: 1147-1150

20. Roubin GS, Cannon AD, Agrawal SK, Macander PJ, Dean LS, Baxley WA, et. al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992; 85: 916-927

21. Buck JJ, De Scheerder I, Beatt K, Van Den Brand M, Suryapranata H, De Feyter PJ, et. al. The importance of adequate anticoagulation to prevent early thrombosis after stenting of stenosed venous bypass grafts. Am Heart J. 1991; 121: 1389-1396

22. Strauss BH, Serruys PW, Bertrand M, Peul J, Meier B, Goy J-J, et. al. Quantitative angiographic follow-up of the coronary Wallstent in native vessels and bypass grafts (European experience-March 1986 to March 1990). Am. J. Cardiol. 1992; 69: 475-481

23. Carrozza JP, Kunitz RE, Levine MJ, Pomerantz RM, Fishman RF, Mansour M,Gibson CM, Senerchia CC, Diver DJ, Safian RD, Baim DS. Angiographic and clinical autcome in intracoronary stenting: immediate and long-term results from a large single-center experience. J. Am Coll. Cardiol. 1992; 20: 328-337

24.Serruys PW. Strauss BH, Beatt KJ, Bertrand ME, Puel J, Rickards AF, Meier B, Goy J-J, Vogt P, Kappenberger L, Sigwart U. Angiographic follow up of a self- expanding coronary-artery stent. N. Engl. J. Med. 1991; 324: 13-17

25. Georg BS, Voorhees WD, Roubin GS, Fearnot NE, Pinkerton CA, Raizer AE, King SB III, Holmes DR, Topol EJ, Kereiakes DJ, Hartzler GO. Mulicenter investigation of coronary stenting to treat acute or threatenal closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J. Am. Coll. Cardiol. 1993; 22: 135-143

26. Nath FC, Muller DWM, Ellis SG, Rosenschein U, Chapekis A, Quain L, Zimmerman C, Topol EJ. Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. J. Am. Coll. Cardiol. 1993; 21: 622-627

27. Sutton JM, Ellis SG, Roubin GS, Pinkerton CA, King SB III, Raizner AE, Holmes DR, Kereiakes DJ, Topol EJ. Major clinical events after coronary stenting: the multicenter registry of acute and elective Gianturco-Roubin stent Placement. Circulation 1994; 89: 1126-1137

28. Levine MJ, Leonard BM, Burke JA, Nash ID, Safian RD, Diver DJ, Baim DS. Clinical and angiographic results of balloon-expandable intracoronary stents in right coronary arteries. J. Am. Coll. Cardiol. 1990; 16: 332-339

29. Karas SP, Gravanis MB, Santioian EC, Robinson KA, Andernerg Ka, King SB III. Coronary intimal proliferation after balloon injury and stenting and stenting in swine: an animal model of restenosis. J. Am. Coll. Cardiol. 1992; 20: 467-474

30. Hanke H, Hassenstein S, Kamenz J, Oberhoff M, Baumbach A, Betz E, KarschKR. Prolonged proliferation response of smooth muscle cells after experimental Intravascular stenting: a stent wire related phenomenon. Circulation 1992; 86(suppl I): 1-186

31. Rogers C, Karnovsky MJ, Edelman ER. Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation 1993; 88: 1215-1221

32. Ellis SG, Savage M, Fishman D, Baim DS, Leon M, Goldberg S, Hirsfeld JW, Cleman MW, Teirstein PS, Walker C, Bailey S, Buchbinder M, Topol EJ, Schatz RA. Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Circulation 1992; 86: 1836-1844

33. Gordon PC, Gibson CM, Cohen DJ, Carozza JP, Kuntz RE, Baim DS. Mechanisms of restenosis and redilation within coronary stents: qualitative angiographic assessment. J. Am. Coll. Cardiol. 1993; 21: 1166-1174

34. Clowes AW, Karnowsky MJ. Supression by heparin of smooth muscle cells proliferation in injured arteries. Nature (Lond). 1977; 265: 625-626

35. Henry PD, Bentley KI. Suppression of atherogenesis in cholesterol-fed rabbits treated with nifedipine. J. Clin. Invest. 1981; 68: 1366-1369

36. Thornton MA, Gruentzig AR, Hollman J, King SB III, Douglas JS Jr. Coumadin and aspirin in the prevention of recurrence after transluminal coronary angioplasty: a randomised study. Circulation 1984; 69: 721-727

37. Corcos T., David PR., Val PG., Renkin J., Dangiosse V, Rapold HG. Bourassa MG. Failure of dltiazem to prevent restenosis after percutaneous Transluminal coronary angioplasty. Am. Heart J. 1985; 109: 926-931

38. Whitworth HB, Roubin GS, Hollman J, Meier B, leimgruber PP, Douglas JS JR, King SB III, Gruentzig AR. Effect of nifedipine in recurrent stenosis after percutaneous coronary angioplasty. J. Am. Coll. Cardiol. 1986; 8: 1271-1276

39. Jonasson L, Hol J, Hansson GK. Cyclosporin A inhibits smooth muscle cell proliferation in the Vascular response to injury. Proc. Natl. Acad. Sci. USA. 1988; 85: 2303-2306

40. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR. Aspirin and dipyridamole in the prevention of restenosis after percutanous transluminal coronary angioplasty. N. Engl. J. Med. 1988; 318:1714-1719

41. Merhi Y, Roy R, Guidoin R, Herbert J, Mourand W, Benslimane S. Cellular reaction to polyester arterial prostheses impregnated with cross-linked albumin: in vivo studies in mice. Biomaterials 1989; 10: 56-58

42. Fischell TA. Polymeric coatings for stents. Circulation 1996; 94: 1494-1495

43. Hehrlein C, Zimmerman M, Grunze M. et. al. Characteristics of metallicly modified stents and their influence on neointima formation in rabbits. Eur. Heart J 1993; 14: 321

44. van der Giessen WJ, Serruyus PW, Visser WJ, et al. Endothelialisation of intravascular stents. J. intervent Cardiol 1988; 1: 109-120

45. Ozaki Y, Violaris G, Serruys PW. New stent technologies. Prog. Cardiov. Dis. 1996; 2: 129-140

46. Hoffman A.S. Modification of Material Surfaces to affect how they interact with blood. An. N.Y. Acad. Sci.

47. Larsson, R, Olsson P, Lindahl U. Inhibition of Thrombin on surfaces coated with immobilized heparin and heparin.like polysaccharides: a crucial non-thrombogenic principle. Thrombosis research 1980; 19: 43-54

48. Williams D.F. Review: Tissue-biomaterial interactions. J. Mater. Sci. 1987; 22: 3421-3445

49. Cook SD, Renz EA, Barrack RL et al. Clinical and netallogical analysis of retrieved internal fixation devices. Clin Orthop 1985; 194: 236-247

50. Brow Sa, Simpson JP. revice and fretting corrosion of stainless steel plates and screws. J Biomed Mater Res 1981; 15: 867-265

51. Colangelo VJ, Greene ND, Corrosion and Fracture of Type 316 SMO orthopedic implants. J Biomt Mater Res 1969; 3: 247-265

52. Emneus H. Some aspects of ostheosynthetic materials as a foreign body. Acta Orthop Scand 1967; 38: 368-418

53.. Emneus H, Stenman U, Baeklund J. An X-ray spectrographic investigation of the soft tissue around titanium and cobalt alloy implants. Acta Orthop Scan 1960; 30: 226-236

54. Emneus H, Stenman U. Metal implants in the human body. Acta Orthop Scand 1965, 36: 115-126

55. Emneus H. Experimental investigations of corrosion of stainless steels used in bone surgery. Acta
Orthop Scand 1961; 44B (suppl): 1-62

56. Tracana R.B., Sousa J.P., Carvalho G.S. Mouse inflammatory response to stainless steel corrosion products. J. Mater. Sci. 1994; 5: 596-600

57. Klein C.L., Nieder P., Wagner M.., Köhler H., Bittinger F., Kirkpatrick C.J., Lewis J.C. The role of metal corrosion in inflammatory processes: induction of adhesion molecules by heavy metal ions. J. Mater. Sci. 1994; 5: 798-807

58. Hunt J.A. Remes A. Williams D.F. Stimulation of neurophil movement be metal ions. J. Biomed. Mater. Sci. 1992; 26: 816-828

59. Tanguay JF, Zindar JP, Philipps HR III. Stack RS. Current status of iodegradable stents. Cardiol Clin 1994; 12: 699-713

60. Herrmann K., Groth TH., Seifert B., Romaniuk K. Heparin-modified polylactide as biodegradable hemocompatible biomaterial. J. Mater. Sci. 1994; 5: 728-731

61. Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, Sato Y, Yokoi H, Hamasaki N, Nosaka H, Nobuyoshi M. Three year follow-up after implantation of metallic coronary- artery stents. N. Engl. J. Med. 1996; 334: 489-495

62. van der Giessen W.J., van Beusekom H.M.M., van Houten C.D., van Woerkens L.J., Verdouw P.D., Serruys P.W. Coronary stenting with polymer-coated and uncoated self-expanding endoprostheses in pigs. Cor. Art. Dis. 1992; 3: 631-640

63. Grant D.M., McColl I.R., Golozar M.A., Wood J.V.. Plasma assisted CVD for biomedical applications. Diamonds and Related Materials 1992; I: 727-730

64. Dion I., Baquey C., Monties J.R.. Diamond: the biomaterial of the 21st century. Inter. J. Art. Org. 1993; 16: 623-627

65. Dion I., Bordenave L., Lefebre F., et al. Physicochemistry and Cytotoxicity of ceramics Part II: Cytotoxicity of ceramics. J of Mater. Sci.: Materials in Medicine 1994; 5: 18-24

66. Dion I., Roques X., Baquey CH., Baudet E., Basse Cathalinat B., More E.. Hemocompatibility of diamond-like carbon coating. Bio-med. Mater. Eng. 1993; 3: 51-55

67. Lu. L., Jones M.W.. Diamond-like carbon as biological compatible material for cell culture and medical application. Bio-Med. Mater. Eng. 1993; 3: 223-228

68. Parker T.L., Parker K.L., McColl I.R., Grant D.M. Wood J.V. The biocompatibility of low temperature diamond-like carbon films: a transmission electron microscopy, scanning electron microscopy and cytotoxicity study. Diamond and related Materials1994; 3: 1120-1123

69. Tang L., Tsai C., Gerberich W.W., Kruckeberg L., Kania D.R. Biocompatibility of chemical-vapour- deposited diamond. Biomaterials 1995; 16: 483-488

70. Thomson L.A., Law F.C., Rushton N. Biocompatibility of diamond-like carbon coating. Biomaterials 1991; 12: 37-40

71. Herbst F. Ionendiffusionsbarriere

72. Yasuda, Hirotsugu, Koge. A method of making a biocompatible prosthesis. PCT application, patent No.: WO89/11919

73. Kobashi K, Nishimura K, Kawate Yoshio, Horiuchi T. Synthesis of diamonds by use of microwave plasma chemical-vapour deposition: Morphology and growth of diamond films. Am. Phys. Soci. Rev. B; 1988: 38-6: 4067-4084

74. Saito Y, Matsuda S, Nogita S. Synthesis of diamond by decomposition of methane in microwave plasma. J. Mater. Sci. Let. 1986; 5: 565-568

75. Robertson J. Mechanical properties and structure of diamond-like carbon. 1992; I: 397-406

76. Geis M.W. Tamor M.A. Diamond and diamond like carbon. Enzcyclo. of Appl. ys. 1993; 5: 1- 24

77. Eversole V, U.S. Patents No. 3,030,187 and No. 3,030,188 1962

78. Deryagin D.V., Fedoseev D.V., Lukyanovich V.M., Spitzin B.V., Ryabov V.A., Lavrentyev A.V. J. Cryst. Growth 1968; 2: 380

79. Deryagin D.V., Builov L.L., Zubkov V.M., Kochergina A.A., Fedoseev D.V. Kristallografiya 1969; 14: 535

80. Deryagin D.V., Lyuttsau D.V., Fedoseev D.V., Ryabov V.A. Dokl. Akad. Nauk SSR 1970; 190: 86

81. Kurihara K, Sasaki K, Kawarada M, Koshio N. High rate synthesis of diamond by dc plasma jet chemical vapor deposition. Appl. Phys. Lett. 1988; 52: 437-8

82. Kobashi K, Nakane A. Glass JT, Buckley-Golder IM. Micro-fabrication of diamond films: selective deposition and etching

83. Soear KE, Frenklach M, Badzian A, Meisser R. Vapor deposition of cristalline diamond; 1085-102

84. Chang CP, Flamme DL, Ibbotson DE, Mucha JA. Diamond crystal growth by plasma chemical vapor deposition. J. Appl. Phys. 1988; 63: 1744-1748

85. Saito Y, Sato K, Gomi K, Miyadera H. Diamond synthesis from COH2 mixed gas plasma. J. of Mater. Sci. 1990; 25: 1246-1250

86. Mitsuda Y, Kojima Y, Yoshida T, Akashi K, the growth of diamonds in microwave plasma under low preassure. J. of Mater. Sci. 1987; 22: 1557-1562

87. Kobashi K, Nishimura K, Kawate Y, Horiuchi T. Synthesis of diamonds by use of microwave plasma chemical vapor deposition : morphology and the growth of diamond films. Physical Review B 1988; 38: 4067-4084

88. Saito Y, Sato K, Tanaka H, Fuijita K, Matsuda S. Diamond synthesis from methan-hydrogen-water mixed gas using a microwave plasma. J. of Mater. Sci. 1988; 23: 842-846

89. Saito Y, Matsuda S, Nogita S. Synthesis of diamond by decomposition of methan in microwave plasma. J. of Mater. Sci. Letters 1986; 5: 565-568

90. Gotman I. Characteristics of metals used in Implants. J. Endourol. 1997 Dec; 11(6): 383-389

91. Mers DC. Metals in medicine and surgery. Int. Met. Rev. 1977; 22: 119-155

92. Williams DF. Titanium and titanium alloys. Williams DF (ed). Biocompatibility of clinical implant materials. Vol II. Boca raton, FL: CRC Press, 1981: 9-44

93. Sutow EJ, Pollack SR. The biocompatibility of cetrain stainless steels. Ibid.: 45-98

94. Williams DF. The properties and clinical uses of cobalt-based alloys. Ibid.: 99-127

95. Woodman J.L. Black J. Nunamaker D.M.. Release of cobalt and nickle from a new total finger joint prosthesis made of vitallium. J. Biomed. Mater. Res. 1983; 17: 655-668

96. Reuling N. Wisser W. Jung A. Denschlag H.O. Release and detection of dental corrosion products in vivo: Development of an experimental model in rabbits. J. Biomed. Mater. Res. 1990; 24: 979-991

97. Brown S.A. Merritt K. Electrochmical corrosion in saline and serum. J. Biomed. Mater. Res.1980; 14: 173-175

98. Brown S.A., Simpson J.P.. Crevice and fretting corrosion of stainless-steel plates and screws. J. Biomed. Mater. Res. 1981; 15: 867-878

99. Woodman J.L., Black J., Jiminez S.A.. Isolation of serum protein organometallic corrosion products from 316LSS and HS-21 in vitro and in vivo. J. Biomed. Mater. Res.; 19: 99-114

100. Berger-Gorbet M., Broxup B., Rivard C., Yahia L' H.. Biocompatibility testing of NiTi screws using immunohistochemistry on sections containing metallic implants. J. Biomed. Mater. Res. 1996; 32: 243-248

© 2003 - 2010 PlasmaChem GmbH. All Rights Reserved. Legal Notices and Terms.